ETON Eton Pharmaceuticals | $15.61
+6.4% | 1/23/2025 | Target Raised by | HC Wainwright | - | Buy | $17.00 -> $33.00 | Medium | View details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 1/23/2025 |
SMTI Sanara MedTech | $38.10
+1.0% | 1/23/2025 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $50.00 -> $50.00 | Low | View details for HC Wainwright rating of Sanara MedTech (NASDAQ:SMTI) on 1/23/2025 |
WKSP Worksport | $0.94
-2.1% | 1/23/2025 | Initiated by | HC Wainwright | Analyst Scott Buck | Buy | $1.50 | Medium | View details for HC Wainwright rating of Worksport (NASDAQ:WKSP) on 1/23/2025 |
RGEN Repligen | $167.70
+0.5% | 1/23/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $240.00 -> $180.00 | Low | View details for HC Wainwright rating of Repligen (NASDAQ:RGEN) on 1/23/2025 |
GMAB Genmab A/S | $21.14
+0.8% | 1/23/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $50.00 -> $50.00 | Low | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 1/23/2025 |
ARWR Arrowhead Pharmaceuticals | $21.04
+6.8% | 1/23/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $80.00 -> $80.00 | High | View details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 1/23/2025 |
NUVB Nuvation Bio | $2.62
-1.3% | 1/23/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $10.00 -> $11.00 | Low | View details for HC Wainwright rating of Nuvation Bio (NYSE:NUVB) on 1/23/2025 |
ESPR Esperion Therapeutics | $2.10
-4.8% | 1/23/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 1/23/2025 |
VALN Valneva | $4.67
+0.9% | 1/23/2025 | Target Lowered by | HC Wainwright | Analyst Edward White | Buy -> Buy | $19.00 -> $18.00 | High | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 1/23/2025 |
PGEN Precigen | $1.31
+15.5% | 1/23/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $4.00 -> $6.00 | High | View details for HC Wainwright rating of Precigen (NASDAQ:PGEN) on 1/23/2025 |
|
CHRS Coherus BioSciences | $1.30
-1.1% | 1/23/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Coherus BioSciences (NASDAQ:CHRS) on 1/23/2025 |
HOTH Hoth Therapeutics | $1.48
+8.8% | 1/23/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Hoth Therapeutics (NASDAQ:HOTH) on 1/23/2025 |
EXOD Exodus Movement | $40.96
-0.1% | 1/23/2025 | Initiated by | HC Wainwright | Analyst Kevin Dede | Buy | $50.00 | N/A | View details for HC Wainwright rating of Exodus Movement (NYSEAMERICAN:EXOD) on 1/23/2025 |
RIGL Rigel Pharmaceuticals | $21.24
-2.6% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $57.00 -> $57.00 | Medium | View details for HC Wainwright rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 1/22/2025 |
ALT Altimmune | $6.98
+0.6% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $12.00 -> $12.00 | Low | View details for HC Wainwright rating of Altimmune (NASDAQ:ALT) on 1/22/2025 |
RVPH Reviva Pharmaceuticals | $1.99
+2.3% | 1/22/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $14.00 -> $11.00 | High | View details for HC Wainwright rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 1/22/2025 |
CAN Canaan | $2.16
-1.1% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $3.00 -> $3.00 | Medium | View details for HC Wainwright rating of Canaan (NASDAQ:CAN) on 1/22/2025 |
ASM Avino Silver & Gold Mines | $1.11
-3.1% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $1.80 -> $1.90 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 1/22/2025 |
ASM Avino Silver & Gold Mines | $1.11
+17.9% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $1.80 -> $1.90 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 1/22/2025 |
DRD DRDGOLD | $10.16
-0.4% | 1/22/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $13.25 -> $17.25 | High | View details for HC Wainwright rating of DRDGOLD (NYSE:DRD) on 1/22/2025 |
EOLS Evolus | $13.80
-2.3% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $27.00 -> $27.00 | High | View details for HC Wainwright rating of Evolus (NASDAQ:EOLS) on 1/22/2025 |
RDW Redwire | $20.91
-3.4% | 1/22/2025 | Target Raised by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $18.00 -> $26.00 | Medium | View details for HC Wainwright rating of Redwire (NYSE:RDW) on 1/22/2025 |
IPSC Century Therapeutics | $0.92
+2.7% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Century Therapeutics (NASDAQ:IPSC) on 1/22/2025 |
MNPR Monopar Therapeutics | $35.86
+6.5% | 1/22/2025 | Target Raised by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $22.00 -> $40.00 | Medium | View details for HC Wainwright rating of Monopar Therapeutics (NASDAQ:MNPR) on 1/22/2025 |
AGEN Agenus | $3.65
-0.3% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Neutral -> Neutral | | High | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 1/22/2025 |
REPL Replimune Group | $13.51
+3.8% | 1/22/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $17.00 -> $21.00 | High | View details for HC Wainwright rating of Replimune Group (NASDAQ:REPL) on 1/22/2025 |
AVBP ArriVent BioPharma | $27.04
+1.5% | 1/22/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $36.00 -> $39.00 | High | View details for HC Wainwright rating of ArriVent BioPharma (NASDAQ:AVBP) on 1/22/2025 |
ATRA Atara Biotherapeutics | $7.01
+1.7% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Neutral -> Neutral | | High | View details for HC Wainwright rating of Atara Biotherapeutics (NASDAQ:ATRA) on 1/22/2025 |
COCP Cocrystal Pharma | $2.01
+0.5% | 1/22/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Cocrystal Pharma (NASDAQ:COCP) on 1/22/2025 |
CYTK Cytokinetics | $46.97
+0.3% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $120.00 -> $120.00 | Low | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 1/21/2025 |
IRON Disc Medicine | $56.27
-3.8% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $118.00 -> $118.00 | Medium | View details for HC Wainwright rating of Disc Medicine (NASDAQ:IRON) on 1/21/2025 |
TLPH Talphera | $0.70
-2.8% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of Talphera (NASDAQ:TLPH) on 1/21/2025 |
ABUS Arbutus Biopharma | $3.20
-0.5% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $5.00 -> $5.00 | Low | View details for HC Wainwright rating of Arbutus Biopharma (NASDAQ:ABUS) on 1/21/2025 |
ETNB 89bio | $6.86
+1.6% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $29.00 -> $29.00 | Medium | View details for HC Wainwright rating of 89bio (NASDAQ:ETNB) on 1/21/2025 |
SMMT Summit Therapeutics | $23.49
-0.1% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $44.00 -> $44.00 | High | View details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 1/21/2025 |
LEGN Legend Biotech | $36.89
-1.5% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $73.00 -> $73.00 | High | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 1/21/2025 |
AXSM Axsome Therapeutics | $103.46
+1.2% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $180.00 -> $180.00 | High | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 1/21/2025 |
VNDA Vanda Pharmaceuticals | $4.40
+1.1% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $18.00 -> $18.00 | High | View details for HC Wainwright rating of Vanda Pharmaceuticals (NASDAQ:VNDA) on 1/21/2025 |
AVXL Anavex Life Sciences | $9.90
-0.9% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $42.00 -> $42.00 | High | View details for HC Wainwright rating of Anavex Life Sciences (NASDAQ:AVXL) on 1/21/2025 |
EBS Emergent BioSolutions | $11.17
+2.7% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of Emergent BioSolutions (NYSE:EBS) on 1/21/2025 |
Trump’s Sending THIS Crypto Higher on Purpose (Ad) Discover the coin set to explode in 2025!
Trump could trigger THIS crypto coin…
 YES, I WANT THE #1 CRYPTO NOW |
VRNA Verona Pharma | $54.45
-0.4% | 1/21/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $42.00 -> $60.00 | High | View details for HC Wainwright rating of Verona Pharma (NASDAQ:VRNA) on 1/21/2025 |
VKTX Viking Therapeutics | $33.72
-1.0% | 1/17/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $102.00 -> $102.00 | Medium | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 1/17/2025 |
CECO CECO Environmental | $29.49
-0.3% | 1/17/2025 | Downgraded by | HC Wainwright | Analyst Amit Dayal | Buy -> Neutral | | High | View details for HC Wainwright rating of CECO Environmental (NASDAQ:CECO) on 1/17/2025 |
OTLK Outlook Therapeutics | $2.04
-2.6% | 1/17/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $30.00 -> $30.00 | High | View details for HC Wainwright rating of Outlook Therapeutics (NASDAQ:OTLK) on 1/17/2025 |
CABA Cabaletta Bio | $2.49
-2.2% | 1/17/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of Cabaletta Bio (NASDAQ:CABA) on 1/17/2025 |
NUVL Nuvalent | $81.57
+0.3% | 1/17/2025 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $110.00 -> $110.00 | Low | View details for HC Wainwright rating of Nuvalent (NASDAQ:NUVL) on 1/17/2025 |
ABSI Absci | $3.97
-1.5% | 1/17/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $7.00 -> $7.00 | Medium | View details for HC Wainwright rating of Absci (NASDAQ:ABSI) on 1/17/2025 |
IPHA Innate Pharma | $1.71
-3.4% | 1/17/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $11.50 -> $11.50 | Low | View details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 1/17/2025 |
AKRO Akero Therapeutics | $25.12
+0.4% | 1/16/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $50.00 -> $50.00 | High | View details for HC Wainwright rating of Akero Therapeutics (NASDAQ:AKRO) on 1/16/2025 |
ARDX Ardelyx | $5.65
+11.9% | 1/16/2025 | Reiterated by | HC Wainwright | Analyst E. Arce | Neutral -> Neutral | $5.50 -> $5.50 | Medium | View details for HC Wainwright rating of Ardelyx (NASDAQ:ARDX) on 1/16/2025 |
HRMY Harmony Biosciences | $36.46
-5.7% | 1/16/2025 | Reiterated by | HC Wainwright | Analyst P. Trucchio | Buy -> Buy | $75.00 -> $75.00 | High | View details for HC Wainwright rating of Harmony Biosciences (NASDAQ:HRMY) on 1/16/2025 |
ITOS iTeos Therapeutics | $7.51
-2.6% | 1/16/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $21.00 -> $21.00 | Low | View details for HC Wainwright rating of iTeos Therapeutics (NASDAQ:ITOS) on 1/16/2025 |
LPTX Leap Therapeutics | $2.39
+3.9% | 1/16/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $5.50 -> $5.50 | High | View details for HC Wainwright rating of Leap Therapeutics (NASDAQ:LPTX) on 1/16/2025 |
IFRX InflaRx | $2.45
-2.0% | 1/16/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $8.00 -> $8.00 | Low | View details for HC Wainwright rating of InflaRx (NASDAQ:IFRX) on 1/16/2025 |
GAU Galiano Gold | $1.17
-0.4% | 1/16/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $4.60 -> $3.10 | N/A | View details for HC Wainwright rating of Galiano Gold (NYSEAMERICAN:GAU) on 1/16/2025 |
APRE Aprea Therapeutics | $4.13
+2.9% | 1/15/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $20.00 -> $20.00 | Low | View details for HC Wainwright rating of Aprea Therapeutics (NASDAQ:APRE) on 1/15/2025 |
APLD Applied Digital | $9.68
+0.4% | 1/15/2025 | Target Raised by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $10.00 -> $12.00 | Medium | View details for HC Wainwright rating of Applied Digital (NASDAQ:APLD) on 1/15/2025 |
RGNX REGENXBIO | $7.85
| 1/15/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $36.00 -> $36.00 | High | View details for HC Wainwright rating of REGENXBIO (NASDAQ:RGNX) on 1/15/2025 |
SRPT Sarepta Therapeutics | $117.19
+0.9% | 1/15/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Sell -> Sell | $75.00 -> $75.00 | Low | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 1/15/2025 |
VCEL Vericel | $57.85
-1.2% | 1/15/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $60.00 -> $60.00 | High | View details for HC Wainwright rating of Vericel (NASDAQ:VCEL) on 1/15/2025 |
ITRG Integra Resources | $0.94
+13.3% | 1/15/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $3.75 -> $2.00 | N/A | View details for HC Wainwright rating of Integra Resources (NYSEAMERICAN:ITRG) on 1/15/2025 |
KPTI Karyopharm Therapeutics | $0.68
+2.3% | 1/15/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Karyopharm Therapeutics (NASDAQ:KPTI) on 1/15/2025 |
TGTX TG Therapeutics | $29.04
-0.3% | 1/15/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $55.00 -> $55.00 | Low | View details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 1/15/2025 |
TVTX Travere Therapeutics | $19.80
+1.7% | 1/15/2025 | Target Raised by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $18.00 -> $22.00 | High | View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 1/15/2025 |
ARGX argenx | $643.37
+0.6% | 1/14/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $670.00 -> $717.00 | Medium | View details for HC Wainwright rating of argenx (NASDAQ:ARGX) on 1/14/2025 |
VTYX Ventyx Biosciences | $2.15
-0.7% | 1/14/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Neutral -> Neutral | | Low | View details for HC Wainwright rating of Ventyx Biosciences (NASDAQ:VTYX) on 1/14/2025 |
AKBA Akebia Therapeutics | $2.29
-4.0% | 1/14/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $7.50 -> $7.50 | Low | View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 1/14/2025 |
FURY Fury Gold Mines | $0.37
-1.6% | 1/14/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $2.00 -> $1.10 | N/A | View details for HC Wainwright rating of Fury Gold Mines (NYSEAMERICAN:FURY) on 1/14/2025 |
DVAX Dynavax Technologies | $12.44
+0.2% | 1/14/2025 | Target Raised by | HC Wainwright | Analyst Edward White | Buy -> Buy | $29.00 -> $31.00 | Medium | View details for HC Wainwright rating of Dynavax Technologies (NASDAQ:DVAX) on 1/14/2025 |
ATEC Alphatec | $11.54
+1.4% | 1/14/2025 | Reiterated by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $20.00 -> $20.00 | Medium | View details for HC Wainwright rating of Alphatec (NASDAQ:ATEC) on 1/14/2025 |
CRVS Corvus Pharmaceuticals | $5.17
-5.0% | 1/14/2025 | Reiterated by | HC Wainwright | Analyst S. Lee | Buy -> Buy | $11.00 -> $11.00 | Medium | View details for HC Wainwright rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 1/14/2025 |
CDNA CareDx | $22.87
-1.4% | 1/14/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Neutral -> Neutral | $26.00 -> $26.00 | High | View details for HC Wainwright rating of CareDx (NASDAQ:CDNA) on 1/14/2025 |
DCTH Delcath Systems | $15.34
+0.9% | 1/14/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $22.00 -> $22.00 | High | View details for HC Wainwright rating of Delcath Systems (NASDAQ:DCTH) on 1/14/2025 |
XFOR X4 Pharmaceuticals | $0.52
+5.6% | 1/14/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $1.50 -> $1.50 | High | View details for HC Wainwright rating of X4 Pharmaceuticals (NASDAQ:XFOR) on 1/14/2025 |
EKSO Ekso Bionics | $0.62
-3.3% | 1/14/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $9.00 -> $9.00 | Low | View details for HC Wainwright rating of Ekso Bionics (NASDAQ:EKSO) on 1/14/2025 |
ELEV Elevation Oncology | $0.67
-0.3% | 1/14/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of Elevation Oncology (NASDAQ:ELEV) on 1/14/2025 |
QSI Quantum-Si | $2.30
-3.6% | 1/14/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $5.50 -> $5.50 | Medium | View details for HC Wainwright rating of Quantum-Si (NASDAQ:QSI) on 1/14/2025 |
BMEA Biomea Fusion | $4.18
-3.4% | 1/14/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $40.00 -> $40.00 | Low | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 1/14/2025 |
VYNE VYNE Therapeutics | $2.73
+0.2% | 1/14/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $5.75 -> $5.75 | High | View details for HC Wainwright rating of VYNE Therapeutics (NASDAQ:VYNE) on 1/14/2025 |
RIGL Rigel Pharmaceuticals | $21.24
-2.6% | 1/14/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $57.00 -> $57.00 | High | View details for HC Wainwright rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 1/14/2025 |
TNYA Tenaya Therapeutics | $1.26
-2.0% | 1/14/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $18.00 -> $18.00 | High | View details for HC Wainwright rating of Tenaya Therapeutics (NASDAQ:TNYA) on 1/14/2025 |
NVCR NovoCure | $26.74
-0.3% | 1/14/2025 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $38.00 -> $38.00 | Medium | View details for HC Wainwright rating of NovoCure (NASDAQ:NVCR) on 1/14/2025 |
APLS Apellis Pharmaceuticals | $30.63
+0.8% | 1/14/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $57.00 -> $57.00 | Medium | View details for HC Wainwright rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 1/14/2025 |
MDGL Madrigal Pharmaceuticals | $328.76
+1.2% | 1/14/2025 | Target Raised by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $390.00 -> $400.00 | High | View details for HC Wainwright rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 1/14/2025 |
NAMS NewAmsterdam Pharma | $22.88
-2.1% | 1/14/2025 | Reiterated by | HC Wainwright | Analyst E. Arce | Buy -> Buy | $48.00 -> $48.00 | Medium | View details for HC Wainwright rating of NewAmsterdam Pharma (NASDAQ:NAMS) on 1/14/2025 |
RLAY Relay Therapeutics | $4.80
-2.5% | 1/14/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of Relay Therapeutics (NASDAQ:RLAY) on 1/14/2025 |
COGT Cogent Biosciences | $8.04
-2.0% | 1/14/2025 | Target Lowered by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $17.00 -> $14.00 | High | View details for HC Wainwright rating of Cogent Biosciences (NASDAQ:COGT) on 1/14/2025 |
CLMT Calumet Specialty Products Partners | $15.79
-1.2% | 1/13/2025 | Target Raised by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $25.00 -> $33.00 | Medium | View details for HC Wainwright rating of Calumet Specialty Products Partners (NASDAQ:CLMT) on 1/13/2025 |
ARCT Arcturus Therapeutics | $16.30
-2.6% | 1/13/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $63.00 -> $63.00 | High | View details for HC Wainwright rating of Arcturus Therapeutics (NASDAQ:ARCT) on 1/13/2025 |
OCGN Ocugen | $0.75
-1.0% | 1/13/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $7.00 -> $7.00 | Low | View details for HC Wainwright rating of Ocugen (NASDAQ:OCGN) on 1/13/2025 |
Trump’s Sending THIS Crypto Higher on Purpose (Ad) Discover the coin set to explode in 2025!
Trump could trigger THIS crypto coin…
YES, I WANT THE #1 CRYPTO NOW |
ALNY Alnylam Pharmaceuticals | $271.04
+1.7% | 1/13/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $400.00 -> $400.00 | High | View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 1/13/2025 |
BCYC Bicycle Therapeutics | $13.47
+2.0% | 1/13/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $33.00 -> $33.00 | High | View details for HC Wainwright rating of Bicycle Therapeutics (NASDAQ:BCYC) on 1/13/2025 |
ORIC ORIC Pharmaceuticals | $10.17
+3.0% | 1/13/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $21.00 -> $21.00 | High | View details for HC Wainwright rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 1/13/2025 |
ATXS Astria Therapeutics | $7.52
+0.2% | 1/13/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 1/13/2025 |
SOUN SoundHound AI | $16.27
-0.7% | 1/13/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $26.00 -> $26.00 | High | View details for HC Wainwright rating of SoundHound AI (NASDAQ:SOUN) on 1/13/2025 |
NB NioCorp Developments | $1.58
-3.7% | 1/13/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $8.50 -> $3.25 | High | View details for HC Wainwright rating of NioCorp Developments (NASDAQ:NB) on 1/13/2025 |
ARQT Arcutis Biotherapeutics | $14.06
+2.5% | 1/13/2025 | Reiterated by | HC Wainwright | Analyst D. Tsao | Buy -> Buy | $19.00 -> $19.00 | High | View details for HC Wainwright rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 1/13/2025 |
CRNX Crinetics Pharmaceuticals | $38.54
-0.3% | 1/13/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $81.00 -> $81.00 | High | View details for HC Wainwright rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 1/13/2025 |
NKTR Nektar Therapeutics | $0.91
-1.3% | 1/13/2025 | Reiterated by | HC Wainwright | Analyst A. He | Buy -> Buy | $6.50 -> $6.50 | High | View details for HC Wainwright rating of Nektar Therapeutics (NASDAQ:NKTR) on 1/13/2025 |
FDMT 4D Molecular Therapeutics | $4.59
-0.4% | 1/13/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $36.00 -> $36.00 | High | View details for HC Wainwright rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 1/13/2025 |
TYRA Tyra Biosciences | $15.99
+1.2% | 1/13/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $30.00 -> $30.00 | High | View details for HC Wainwright rating of Tyra Biosciences (NASDAQ:TYRA) on 1/13/2025 |
RLYB Rallybio | $0.90
+3.6% | 1/13/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for HC Wainwright rating of Rallybio (NASDAQ:RLYB) on 1/13/2025 |
BRNS Barinthus Biotherapeutics | $1.06
+0.6% | 1/13/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $5.00 -> $3.00 | High | View details for HC Wainwright rating of Barinthus Biotherapeutics (NASDAQ:BRNS) on 1/13/2025 |
INO Inovio Pharmaceuticals | $2.30
+2.0% | 1/13/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Neutral -> Neutral | $5.00 -> $3.00 | Low | View details for HC Wainwright rating of Inovio Pharmaceuticals (NASDAQ:INO) on 1/13/2025 |
YMAB Y-mAbs Therapeutics | $6.17
-0.4% | 1/13/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $22.00 -> $22.00 | High | View details for HC Wainwright rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 1/13/2025 |
INZY Inozyme Pharma | $1.29
-1.2% | 1/10/2025 | Target Raised by | HC Wainwright | Analyst Edward White | Buy -> Buy | $14.00 -> $16.00 | High | View details for HC Wainwright rating of Inozyme Pharma (NASDAQ:INZY) on 1/10/2025 |
ACXP Acurx Pharmaceuticals | $0.84
-1.1% | 1/10/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of Acurx Pharmaceuticals (NASDAQ:ACXP) on 1/10/2025 |
DYN Dyne Therapeutics | $13.96
-1.0% | 1/10/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $55.00 -> $55.00 | High | View details for HC Wainwright rating of Dyne Therapeutics (NASDAQ:DYN) on 1/10/2025 |
CGON CG Oncology | $30.34
+0.4% | 1/10/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $75.00 -> $75.00 | Low | View details for HC Wainwright rating of CG Oncology (NASDAQ:CGON) on 1/10/2025 |
GHRS GH Research | $8.86
+0.7% | 1/10/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $40.00 -> $40.00 | Low | View details for HC Wainwright rating of GH Research (NASDAQ:GHRS) on 1/10/2025 |
SLDB Solid Biosciences | $3.08
-1.3% | 1/10/2025 | Reiterated by | HC Wainwright | Analyst Arthur He | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of Solid Biosciences (NASDAQ:SLDB) on 1/10/2025 |
AG First Majestic Silver | $5.58
-0.6% | 1/10/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $11.00 -> $11.00 | Medium | View details for HC Wainwright rating of First Majestic Silver (NYSE:AG) on 1/10/2025 |
JSPR Jasper Therapeutics | $6.08
+1.1% | 1/10/2025 | Target Lowered by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $60.00 -> $40.00 | Medium | View details for HC Wainwright rating of Jasper Therapeutics (NASDAQ:JSPR) on 1/10/2025 |
CPRX Catalyst Pharmaceuticals | $22.38
-2.1% | 1/10/2025 | Target Raised by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $30.00 -> $35.00 | High | View details for HC Wainwright rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 1/10/2025 |
EXEL Exelixis | $33.17
+0.9% | 1/10/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $29.00 -> $40.00 | High | View details for HC Wainwright rating of Exelixis (NASDAQ:EXEL) on 1/10/2025 |
ANGO AngioDynamics | $12.24
+1.5% | 1/10/2025 | Target Raised by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $14.00 -> $15.00 | High | View details for HC Wainwright rating of AngioDynamics (NASDAQ:ANGO) on 1/10/2025 |
PVLA Palvella Therapeutics | $12.92
-1.7% | 1/10/2025 | Reiterated by | HC Wainwright | Analyst A. Fein | Buy -> Buy | $38.00 -> $38.00 | Low | View details for HC Wainwright rating of Palvella Therapeutics (NASDAQ:PVLA) on 1/10/2025 |
KMDA Kamada | $7.26
-3.6% | 1/10/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $11.00 -> $11.00 | High | View details for HC Wainwright rating of Kamada (NASDAQ:KMDA) on 1/10/2025 |
COLL Collegium Pharmaceutical | $32.70
+0.4% | 1/10/2025 | Reiterated by | HC Wainwright | Analyst O. Livnat | Buy -> Buy | $50.00 -> $50.00 | High | View details for HC Wainwright rating of Collegium Pharmaceutical (NASDAQ:COLL) on 1/10/2025 |
VIR Vir Biotechnology | $10.97
+4.2% | 1/10/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | $110.00 -> $110.00 | Medium | View details for HC Wainwright rating of Vir Biotechnology (NASDAQ:VIR) on 1/10/2025 |
EXK Endeavour Silver | $3.59
+0.4% | 1/10/2025 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $7.25 -> $7.00 | Low | View details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 1/10/2025 |
EMX EMX Royalty | $1.72
-0.3% | 1/10/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of EMX Royalty (NYSEAMERICAN:EMX) on 1/10/2025 |
RICK RCI Hospitality | $54.39
+0.5% | 1/10/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | $98.00 -> $98.00 | High | View details for HC Wainwright rating of RCI Hospitality (NASDAQ:RICK) on 1/10/2025 |
DTIL Precision BioSciences | $4.90
-1.5% | 1/10/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $60.00 -> $60.00 | High | View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 1/10/2025 |
DRUG Bright Minds Biosciences | $32.41
-2.8% | 1/10/2025 | Initiated by | HC Wainwright | Analyst P. Trucchio | Buy | $85.00 | High | View details for HC Wainwright rating of Bright Minds Biosciences (NASDAQ:DRUG) on 1/10/2025 |
CYTK Cytokinetics | $46.97
+0.3% | 1/10/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $120.00 -> $120.00 | High | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 1/10/2025 |
ESPR Esperion Therapeutics | $2.10
-4.8% | 1/10/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | | High | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 1/10/2025 |
APTO Aptose Biosciences | $0.20
-2.3% | 1/10/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $2.00 -> $2.00 | High | View details for HC Wainwright rating of Aptose Biosciences (NASDAQ:APTO) on 1/10/2025 |
MDWD MediWound | $18.38
-0.2% | 1/10/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of MediWound (NASDAQ:MDWD) on 1/10/2025 |
AVDL Avadel Pharmaceuticals | $8.03
+0.4% | 1/10/2025 | Reiterated by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $25.00 -> $21.00 | High | View details for HC Wainwright rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 1/10/2025 |
HOOK Hookipa Pharma | $1.96
-1.8% | 1/10/2025 | Reiterated by | HC Wainwright | Analyst A. He | Buy -> Neutral | | High | View details for HC Wainwright rating of Hookipa Pharma (NASDAQ:HOOK) on 1/10/2025 |
EBS Emergent BioSolutions | $11.17
+2.7% | 1/10/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $15.00 -> $15.00 | Low | View details for HC Wainwright rating of Emergent BioSolutions (NYSE:EBS) on 1/10/2025 |
MLTX MoonLake Immunotherapeutics | $46.98
-0.3% | 1/10/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $100.00 -> $100.00 | High | View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 1/10/2025 |
RNA Avidity Biosciences | $29.21
-2.9% | 1/10/2025 | Reiterated by | HC Wainwright | Analyst A. Ghosh | Buy -> Buy | $72.00 -> $72.00 | High | View details for HC Wainwright rating of Avidity Biosciences (NASDAQ:RNA) on 1/10/2025 |
HALO Halozyme Therapeutics | $55.53
+0.5% | 1/10/2025 | Target Raised by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $68.00 -> $70.00 | High | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 1/10/2025 |
PHGE BiomX | $0.75
+2.6% | 1/8/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for HC Wainwright rating of BiomX (NYSEAMERICAN:PHGE) on 1/8/2025 |
ABSI Absci | $3.97
-1.5% | 1/8/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Absci (NASDAQ:ABSI) on 1/8/2025 |
CMPX Compass Therapeutics | $3.01
+16.6% | 1/8/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Compass Therapeutics (NASDAQ:CMPX) on 1/8/2025 |
VKTX Viking Therapeutics | $33.72
-1.0% | 1/8/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $102.00 -> $102.00 | Medium | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 1/8/2025 |
SNSE Sensei Biotherapeutics | $0.53
-3.0% | 1/8/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Sensei Biotherapeutics (NASDAQ:SNSE) on 1/8/2025 |
Trump’s Sending THIS Crypto Higher on Purpose (Ad) Discover the coin set to explode in 2025!
Trump could trigger THIS crypto coin…
YES, I WANT THE #1 CRYPTO NOW |
GMAB Genmab A/S | $21.14
+0.8% | 1/8/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 -> $50.00 | Low | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 1/8/2025 |
SANA Sana Biotechnology | $3.57
+1.9% | 1/8/2025 | Target Raised by | HC Wainwright | - | Buy -> Buy | $8.00 -> $11.00 | High | View details for HC Wainwright rating of Sana Biotechnology (NASDAQ:SANA) on 1/8/2025 |
STOK Stoke Therapeutics | $10.29
+2.7% | 1/8/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | $35.00 -> $35.00 | High | View details for HC Wainwright rating of Stoke Therapeutics (NASDAQ:STOK) on 1/8/2025 |
OPK OPKO Health | $1.49
+1.0% | 1/8/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 -> $3.00 | Medium | View details for HC Wainwright rating of OPKO Health (NASDAQ:OPK) on 1/8/2025 |
PSNL Personalis | $5.89
+5.2% | 1/8/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $11.00 | High | View details for HC Wainwright rating of Personalis (NASDAQ:PSNL) on 1/8/2025 |
UNCY Unicycive Therapeutics | $0.62
-0.1% | 1/8/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Unicycive Therapeutics (NASDAQ:UNCY) on 1/8/2025 |
PPTA Perpetua Resources | $12.26
+0.1% | 1/7/2025 | Target Raised by | HC Wainwright | - | Buy -> Buy | $22.00 -> $25.00 | Low | View details for HC Wainwright rating of Perpetua Resources (NASDAQ:PPTA) on 1/7/2025 |
XOMA XOMA | $26.25
+0.8% | 1/7/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | $123.00 -> $123.00 | Medium | View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 1/7/2025 |
USGO U.S. GoldMining | $8.77
-0.8% | 1/7/2025 | Target Raised by | HC Wainwright | - | Buy -> Buy | $24.00 -> $26.50 | Medium | View details for HC Wainwright rating of U.S. GoldMining (NASDAQ:USGO) on 1/7/2025 |
SLRN Acelyrin | $1.97
-2.7% | 1/7/2025 | Target Lowered by | HC Wainwright | Analyst E. Bodnar | Neutral -> Neutral | $8.00 -> $6.00 | High | View details for HC Wainwright rating of Acelyrin (NASDAQ:SLRN) on 1/7/2025 |
ARCT Arcturus Therapeutics | $16.30
-2.6% | 1/7/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | $63.00 -> $63.00 | High | View details for HC Wainwright rating of Arcturus Therapeutics (NASDAQ:ARCT) on 1/7/2025 |
CTMX CytomX Therapeutics | $0.85
+1.9% | 1/7/2025 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | | High | View details for HC Wainwright rating of CytomX Therapeutics (NASDAQ:CTMX) on 1/7/2025 |
DNLI Denali Therapeutics | $22.85
-2.0% | 1/7/2025 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $90.00 -> $87.00 | High | View details for HC Wainwright rating of Denali Therapeutics (NASDAQ:DNLI) on 1/7/2025 |
OCS Oculis | $22.67
-0.1% | 1/6/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 1/6/2025 |
VYNE VYNE Therapeutics | $2.73
+0.2% | 1/6/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.75 -> $5.75 | N/A | View details for HC Wainwright rating of VYNE Therapeutics (NASDAQ:VYNE) on 1/6/2025 |
ETON Eton Pharmaceuticals | $15.61
+6.4% | 1/6/2025 | Target Raised by | HC Wainwright | - | Buy -> Buy | $15.00 -> $17.00 | N/A | View details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 1/6/2025 |
ADCT ADC Therapeutics | $1.71
+0.3% | 1/6/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 -> $8.00 | N/A | View details for HC Wainwright rating of ADC Therapeutics (NYSE:ADCT) on 1/6/2025 |
IMMX Immix Biopharma | $1.97
-0.8% | 1/6/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Immix Biopharma (NASDAQ:IMMX) on 1/6/2025 |
NUVB Nuvation Bio | $2.62
-1.3% | 1/6/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Nuvation Bio (NYSE:NUVB) on 1/6/2025 |
ALMS Alumis | $6.48
-6.1% | 1/6/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $26.00 -> $26.00 | N/A | View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 1/6/2025 |
NMRA Neumora Therapeutics | $2.01
-3.6% | 1/3/2025 | Reiterated by | HC Wainwright | Analyst D. Tsao | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for HC Wainwright rating of Neumora Therapeutics (NASDAQ:NMRA) on 1/3/2025 |
OPTN OptiNose | $6.60
-1.4% | 1/3/2025 | Target Raised by | HC Wainwright | - | Buy -> Buy | $5.00 -> $18.00 | N/A | View details for HC Wainwright rating of OptiNose (NASDAQ:OPTN) on 1/3/2025 |
PVLA Palvella Therapeutics | $12.92
-1.7% | 1/3/2025 | Reiterated by | HC Wainwright | Analyst A. Fein | Buy -> Buy | $38.00 -> $38.00 | N/A | View details for HC Wainwright rating of Palvella Therapeutics (NASDAQ:PVLA) on 1/3/2025 |
LPTH LightPath Technologies | $3.27
-4.8% | 1/3/2025 | Target Raised by | HC Wainwright | - | Buy -> Buy | $3.00 -> $5.00 | N/A | View details for HC Wainwright rating of LightPath Technologies (NASDAQ:LPTH) on 1/3/2025 |
CAPR Capricor Therapeutics | $14.59
-2.1% | 1/2/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | $77.00 -> $77.00 | N/A | View details for HC Wainwright rating of Capricor Therapeutics (NASDAQ:CAPR) on 1/2/2025 |
SGMO Sangamo Therapeutics | $1.15
-0.4% | 1/2/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Sangamo Therapeutics (NASDAQ:SGMO) on 1/2/2025 |
VERU Veru | $1.19
+13.9% | 1/2/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 -> $3.00 | N/A | View details for HC Wainwright rating of Veru (NASDAQ:VERU) on 1/2/2025 |
CRVS Corvus Pharmaceuticals | $5.17
-5.0% | 1/2/2025 | Initiated by | HC Wainwright | Analyst S. Lee | Buy | $11.00 | N/A | View details for HC Wainwright rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 1/2/2025 |
ARQQ Arqit Quantum | $27.12
-6.9% | 12/31/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $27.00 -> $52.00 | N/A | View details for HC Wainwright rating of Arqit Quantum (NASDAQ:ARQQ) on 12/31/2024 |
AXSM Axsome Therapeutics | $103.46
+1.2% | 12/31/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | | N/A | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 12/31/2024 |
CMRX Chimerix | $3.95
+4.5% | 12/30/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $11.00 | N/A | View details for HC Wainwright rating of Chimerix (NASDAQ:CMRX) on 12/30/2024 |
HALO Halozyme Therapeutics | $55.53
+0.5% | 12/30/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $68.00 -> $68.00 | N/A | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 12/30/2024 |
BBAI BigBear.ai | $4.20
-5.5% | 12/30/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $3.00 -> $7.00 | N/A | View details for HC Wainwright rating of BigBear.ai (NYSE:BBAI) on 12/30/2024 |
NUVL Nuvalent | $81.57
+0.3% | 12/30/2024 | Initiated by | HC Wainwright | Analyst S. Ramakanth | Buy | $110.00 | N/A | View details for HC Wainwright rating of Nuvalent (NASDAQ:NUVL) on 12/30/2024 |
NAMS NewAmsterdam Pharma | $22.88
-2.1% | 12/30/2024 | Initiated by | HC Wainwright | Analyst E. Arce | Buy | $48.00 | N/A | View details for HC Wainwright rating of NewAmsterdam Pharma (NASDAQ:NAMS) on 12/30/2024 |
MTVA MetaVia | $1.94
+3.2% | 12/30/2024 | Initiated by | HC Wainwright | Analyst E. Arce | Buy | $12.00 | N/A | View details for HC Wainwright rating of MetaVia (NASDAQ:MTVA) on 12/30/2024 |
EBS Emergent BioSolutions | $11.17
+2.7% | 12/30/2024 | Initiated by | HC Wainwright | Analyst R. Selvaraju | Buy | $15.00 | N/A | View details for HC Wainwright rating of Emergent BioSolutions (NYSE:EBS) on 12/30/2024 |
ARTV Artiva Biotherapeutics | $6.29
-4.0% | 12/30/2024 | Initiated by | HC Wainwright | Analyst E. White | Buy | $20.00 | N/A | View details for HC Wainwright rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 12/30/2024 |
ARQT Arcutis Biotherapeutics | $14.06
+2.5% | 12/30/2024 | Initiated by | HC Wainwright | Analyst D. Tsao | Buy | $19.00 | N/A | View details for HC Wainwright rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 12/30/2024 |
GALT Galectin Therapeutics | $1.22
+0.4% | 12/27/2024 | Reiterated by | HC Wainwright | Analyst E. Arce | Buy -> Neutral | | N/A | View details for HC Wainwright rating of Galectin Therapeutics (NASDAQ:GALT) on 12/27/2024 |
ASMB Assembly Biosciences | $14.78
-1.2% | 12/27/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | | N/A | View details for HC Wainwright rating of Assembly Biosciences (NASDAQ:ASMB) on 12/27/2024 |
PYPD PolyPid | $3.19
-1.4% | 12/26/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $14.00 -> $11.00 | N/A | View details for HC Wainwright rating of PolyPid (NASDAQ:PYPD) on 12/26/2024 |
AVXL Anavex Life Sciences | $9.90
-0.9% | 12/26/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $40.00 -> $42.00 | N/A | View details for HC Wainwright rating of Anavex Life Sciences (NASDAQ:AVXL) on 12/26/2024 |
PVLA Palvella Therapeutics | $12.92
-1.7% | 12/26/2024 | Initiated by | HC Wainwright | Analyst A. Fein | Buy | $38.00 | N/A | View details for HC Wainwright rating of Palvella Therapeutics (NASDAQ:PVLA) on 12/26/2024 |
RAPT RAPT Therapeutics | $1.19
-2.9% | 12/26/2024 | Upgraded by | HC Wainwright | Analyst R. Selvaraju | Neutral -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of RAPT Therapeutics (NASDAQ:RAPT) on 12/26/2024 |
BTCS BTCS | $3.42
+9.5% | 12/24/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $3.00 -> $5.00 | N/A | View details for HC Wainwright rating of BTCS (NASDAQ:BTCS) on 12/24/2024 |
FPAY FlexShopper | $1.45
-2.4% | 12/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.50 -> $2.50 | N/A | View details for HC Wainwright rating of FlexShopper (NASDAQ:FPAY) on 12/24/2024 |
ZURA Zura Bio | $1.72
-4.2% | 12/24/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Neutral -> Neutral | $5.00 -> $5.00 | N/A | View details for HC Wainwright rating of Zura Bio (NASDAQ:ZURA) on 12/24/2024 |
ENTA Enanta Pharmaceuticals | $5.36
+3.5% | 12/24/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $27.00 -> $18.00 | N/A | View details for HC Wainwright rating of Enanta Pharmaceuticals (NASDAQ:ENTA) on 12/24/2024 |
RARE Ultragenyx Pharmaceutical | $43.66
+1.7% | 12/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $95.00 -> $95.00 | N/A | View details for HC Wainwright rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 12/24/2024 |
Trump’s Sending THIS Crypto Higher on Purpose (Ad) Discover the coin set to explode in 2025!
Trump could trigger THIS crypto coin…
YES, I WANT THE #1 CRYPTO NOW |
NDA Neptune Digital Assets | C$1.86
+3.9% | 12/23/2024 | Target Raised by | HC Wainwright | - | Buy | C$1.00 -> C$2.00 | N/A | View details for HC Wainwright rating of Neptune Digital Assets (CVE:NDA) on 12/23/2024 |
PBYI Puma Biotechnology | $2.95
-0.2% | 12/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Puma Biotechnology (NASDAQ:PBYI) on 12/23/2024 |
AMTX Aemetis | $2.32
+7.7% | 12/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 -> $28.00 | N/A | View details for HC Wainwright rating of Aemetis (NASDAQ:AMTX) on 12/23/2024 |
REE REE Automotive | $9.27
-1.3% | 12/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of REE Automotive (NASDAQ:REE) on 12/23/2024 |
VYNE VYNE Therapeutics | $2.73
+0.2% | 12/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.75 -> $5.75 | N/A | View details for HC Wainwright rating of VYNE Therapeutics (NASDAQ:VYNE) on 12/23/2024 |
SOUN SoundHound AI | $16.27
-0.7% | 12/23/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $8.00 -> $26.00 | N/A | View details for HC Wainwright rating of SoundHound AI (NASDAQ:SOUN) on 12/23/2024 |
BWAY BrainsWay | $11.02
-0.3% | 12/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for HC Wainwright rating of BrainsWay (NASDAQ:BWAY) on 12/23/2024 |
RMTI Rockwell Medical | $2.22
+1.6% | 12/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 12/23/2024 |
RYTM Rhythm Pharmaceuticals | $57.28
+0.1% | 12/23/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $69.00 -> $69.00 | N/A | View details for HC Wainwright rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 12/23/2024 |
VNDA Vanda Pharmaceuticals | $4.40
+1.1% | 12/23/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for HC Wainwright rating of Vanda Pharmaceuticals (NASDAQ:VNDA) on 12/23/2024 |
SMTI Sanara MedTech | $38.10
+1.0% | 12/23/2024 | Initiated by | HC Wainwright | Analyst Y. Chen | Buy | $50.00 | N/A | View details for HC Wainwright rating of Sanara MedTech (NASDAQ:SMTI) on 12/23/2024 |
ENGN enGene | $7.14
+2.7% | 12/23/2024 | Initiated by | HC Wainwright | Analyst A. Maldonado | Buy | $25.00 | N/A | View details for HC Wainwright rating of enGene (NASDAQ:ENGN) on 12/23/2024 |
ACRS Aclaris Therapeutics | $2.56
-1.7% | 12/23/2024 | Upgraded by | HC Wainwright | Analyst R. Selvaraju | Neutral -> Buy | $20.00 -> $20.00 | N/A | View details for HC Wainwright rating of Aclaris Therapeutics (NASDAQ:ACRS) on 12/23/2024 |
PYXS Pyxis Oncology | $1.62
+3.6% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $5.00 | N/A | View details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 12/20/2024 |
IFRX InflaRx | $2.45
-2.0% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 -> $8.00 | N/A | View details for HC Wainwright rating of InflaRx (NASDAQ:IFRX) on 12/20/2024 |
ARWR Arrowhead Pharmaceuticals | $21.04
+6.8% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $80.00 -> $80.00 | N/A | View details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 12/20/2024 |
CYTK Cytokinetics | $46.97
+0.3% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $120.00 -> $120.00 | N/A | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 12/20/2024 |
LGO Largo | $1.75
+1.5% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.20 -> $4.20 | N/A | View details for HC Wainwright rating of Largo (NYSE:LGO) on 12/20/2024 |
HUMA Humacyte | $4.43
-3.6% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $15.00 | N/A | View details for HC Wainwright rating of Humacyte (NASDAQ:HUMA) on 12/20/2024 |
PSNL Personalis | $5.89
+5.2% | 12/20/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $9.00 -> $11.00 | N/A | View details for HC Wainwright rating of Personalis (NASDAQ:PSNL) on 12/20/2024 |
VRTX Vertex Pharmaceuticals | $433.56
+1.3% | 12/20/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $600.00 -> $535.00 | N/A | View details for HC Wainwright rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 12/20/2024 |
PRTA Prothena | $14.85
+2.9% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $84.00 -> $48.00 | N/A | View details for HC Wainwright rating of Prothena (NASDAQ:PRTA) on 12/20/2024 |
VERU Veru | $1.19
+13.9% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 -> $3.00 | N/A | View details for HC Wainwright rating of Veru (NASDAQ:VERU) on 12/20/2024 |
ORKA Oruka Therapeutics | $12.42
-0.6% | 12/20/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $45.00 -> $45.00 | N/A | View details for HC Wainwright rating of Oruka Therapeutics (NASDAQ:ORKA) on 12/20/2024 |
ALMS Alumis | $6.48
-6.1% | 12/20/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $26.00 -> $26.00 | N/A | View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 12/20/2024 |
AQST Aquestive Therapeutics | $3.14
-0.2% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 12/20/2024 |
FNV Franco-Nevada | $128.73
-0.9% | 12/20/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $200.00 -> $155.00 | N/A | View details for HC Wainwright rating of Franco-Nevada (NYSE:FNV) on 12/20/2024 |
RNA Avidity Biosciences | $29.21
-2.9% | 12/20/2024 | Initiated by | HC Wainwright | Analyst A. Ghosh | Buy | $72.00 | N/A | View details for HC Wainwright rating of Avidity Biosciences (NASDAQ:RNA) on 12/20/2024 |
AIRJ Montana Technologies | $8.16
-7.0% | 12/20/2024 | Initiated by | HC Wainwright | Analyst A. Dayal | Buy | $12.00 | N/A | View details for HC Wainwright rating of Montana Technologies (NASDAQ:AIRJ) on 12/20/2024 |
CLDX Celldex Therapeutics | $23.86
-1.6% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $80.00 -> $80.00 | N/A | View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 12/19/2024 |
IMNN Imunon | $0.93
+4.5% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Imunon (NASDAQ:IMNN) on 12/19/2024 |
GPCR Structure Therapeutics | $27.60
-1.2% | 12/19/2024 | Reiterated by | HC Wainwright | Analyst A. Ghosh | Buy -> Buy | $80.00 -> $80.00 | N/A | View details for HC Wainwright rating of Structure Therapeutics (NASDAQ:GPCR) on 12/19/2024 |
PTN Palatin Technologies | $0.97
+1.0% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for HC Wainwright rating of Palatin Technologies (NYSEAMERICAN:PTN) on 12/19/2024 |
ACET Adicet Bio | $0.90
-1.6% | 12/19/2024 | Reiterated by | HC Wainwright | Analyst E. White | Neutral -> Neutral | | N/A | View details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 12/19/2024 |
SGMO Sangamo Therapeutics | $1.15
-0.4% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Sangamo Therapeutics (NASDAQ:SGMO) on 12/19/2024 |
ARMP Armata Pharmaceuticals | $2.27
+3.4% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Armata Pharmaceuticals (NYSEAMERICAN:ARMP) on 12/19/2024 |
UROY Uranium Royalty | $2.51
-1.8% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.70 -> $7.70 | N/A | View details for HC Wainwright rating of Uranium Royalty (NASDAQ:UROY) on 12/19/2024 |
VSTM Verastem | $5.49
-0.6% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Verastem (NASDAQ:VSTM) on 12/19/2024 |
SRPT Sarepta Therapeutics | $117.19
+0.9% | 12/19/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Sell -> Sell | $75.00 -> $75.00 | N/A | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 12/19/2024 |
CGTX Cognition Therapeutics | $0.76
-1.2% | 12/19/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $5.00 -> $6.00 | N/A | View details for HC Wainwright rating of Cognition Therapeutics (NASDAQ:CGTX) on 12/19/2024 |
WRN Western Copper & Gold | $1.02
-0.4% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.25 -> $4.25 | N/A | View details for HC Wainwright rating of Western Copper & Gold (NYSE:WRN) on 12/18/2024 |
VKTX Viking Therapeutics | $33.72
-1.0% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $102.00 -> $102.00 | N/A | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 12/18/2024 |
TNYA Tenaya Therapeutics | $1.26
-2.0% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for HC Wainwright rating of Tenaya Therapeutics (NASDAQ:TNYA) on 12/18/2024 |
JOBY Joby Aviation | $8.48
-3.4% | 12/18/2024 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for HC Wainwright rating of Joby Aviation (NYSE:JOBY) on 12/18/2024 |
RICK RCI Hospitality | $54.39
+0.5% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $98.00 -> $98.00 | N/A | View details for HC Wainwright rating of RCI Hospitality (NASDAQ:RICK) on 12/18/2024 |
EXK Endeavour Silver | $3.59
+0.4% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.25 -> $7.25 | N/A | View details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 12/18/2024 |
HALO Halozyme Therapeutics | $55.53
+0.5% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $68.00 -> $68.00 | N/A | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 12/18/2024 |
ECOR electroCore | $15.81
-1.9% | 12/18/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $22.00 -> $25.00 | N/A | View details for HC Wainwright rating of electroCore (NASDAQ:ECOR) on 12/18/2024 |
ALXO ALX Oncology | $1.51
-16.4% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for HC Wainwright rating of ALX Oncology (NASDAQ:ALXO) on 12/18/2024 |
PDSB PDS Biotechnology | $1.56
-7.1% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 -> $21.00 | N/A | View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 12/18/2024 |
KRYS Krystal Biotech | $151.01
-1.6% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $221.00 -> $221.00 | N/A | View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 12/18/2024 |
CADL Candel Therapeutics | $6.87
+0.4% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $19.00 | N/A | View details for HC Wainwright rating of Candel Therapeutics (NASDAQ:CADL) on 12/18/2024 |
CRDL Cardiol Therapeutics | $1.33
+0.4% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 12/18/2024 |
FGEN FibroGen | $0.54
+6.2% | 12/17/2024 | Upgraded by | HC Wainwright | Analyst M. Keller | Strong-Buy | | N/A | View details for HC Wainwright rating of FibroGen (NASDAQ:FGEN) on 12/17/2024 |
HRMY Harmony Biosciences | $36.46
-5.7% | 12/17/2024 | Initiated by | HC Wainwright | Analyst P. Trucchio | Buy | $75.00 | N/A | View details for HC Wainwright rating of Harmony Biosciences (NASDAQ:HRMY) on 12/17/2024 |
MITK Mitek Systems | $9.86
+0.6% | 12/17/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $11.00 -> $13.00 | N/A | View details for HC Wainwright rating of Mitek Systems (NASDAQ:MITK) on 12/17/2024 |
NMG Nouveau Monde Graphite | $2.01
+0.8% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 -> $3.00 | N/A | View details for HC Wainwright rating of Nouveau Monde Graphite (NYSE:NMG) on 12/17/2024 |
ARCT Arcturus Therapeutics | $16.30
-2.6% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $63.00 -> $63.00 | N/A | View details for HC Wainwright rating of Arcturus Therapeutics (NASDAQ:ARCT) on 12/17/2024 |
DARE Daré Bioscience | $3.28
| 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Daré Bioscience (NASDAQ:DARE) on 12/17/2024 |
BHVN Biohaven | $39.60
-2.4% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $59.00 -> $59.00 | N/A | View details for HC Wainwright rating of Biohaven (NYSE:BHVN) on 12/17/2024 |
